ImmunoDiagnostics Limited (IMD) is a spin-off biotech company from Immunoassay Services (AIS) from the University of Hong Kong (HKU), and has R&D activities in both Toronto, Canada, and Hong Kong. The founders of IMD are academic professoriates with strong research background in immunology, metabolism, cardiovascular medicine, and antibody and protein engineering. The company has over 12 years of experience in biomarker discovery and development of highly specific immunoassays for both research & in vitro diagnostics (IVD) for major infectious diseases, cardiometabolic disorders and autoimmune diseases.
IMD’s Mission is to be the worldwide pioneer in the production and manufacture of research products regarding immuno-metabolism.